TBI-223

· Global Alliance for TB Drug Development

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TBI-223, covering 2024-12-09 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects [Phase 1]